Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2014196817) COMPOSITION CONTAINING XYLITOL AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING INFLUENZA VIRUS INFECTION
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2014/196817 International Application No.: PCT/KR2014/004987
Publication Date: 11.12.2014 International Filing Date: 05.06.2014
IPC:
A61K 31/047 (2006.01) ,A61K 31/045 (2006.01) ,A61P 31/16 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
045
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
047
having two or more hydroxy groups, e.g. sorbitol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
045
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12
Antivirals
14
for RNA viruses
16
for influenza or rhinoviruses
Applicants:
중앙대학교 산학협력단 CHUNG-ANG UNIVERSITY INDUSTRY-ACADEMY COOPERATION FOUNDATION [KR/KR]; 서울시 동작구 흑석로 84 84, Heukseok-ro Dongjak-gu Seoul 156-756, KR
Inventors:
김홍진 KIM, Hong Jin; KR
인선영 YIN, Sun Young; KR
김형진 KIM, Hyoung Jin; KR
Agent:
특허법인 태백 TAEBAEK INTELLECTUAL PROPERTY LAW FIRM; 서울시 금천구 가산디지털1로151 이노플렉스1차 601호 #601 Innoplex 1 cha, 151Gasandigital 1-ro Geumcheon-gu Seoul 153-803, KR
Priority Data:
10-2013-006407804.06.2013KR
10-2014-006806205.06.2014KR
Title (EN) COMPOSITION CONTAINING XYLITOL AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING INFLUENZA VIRUS INFECTION
(FR) COMPOSITION CONTENANT DU XYLITOL EN TANT QUE PRINCIPE ACTIF POUR LA PRÉVENTION OU LE TRAITEMENT D'UNE INFECTION PAR LE VIRUS GRIPPAL
(KO) 자일리톨을 유효성분으로 함유하는 인플루엔자 바이러스 감염증 예방 또는 치료용 조성물
Abstract:
(EN) The present invention relates to a pharmaceutical composition containing xylitol as an active ingredient, for preventing or treating an influenza virus infection. In particular, the pharmaceutical composition further comprises one or more selected from the group consisting of a ginseng or red ginseng water dialysis layer, an entire ginseng or red ginseng extract, a ginseng or red ginseng polysaccharide, and a ginseng or red ginseng saponin. Further, the present invention provides a health food composition containing xylitol; and one or more selected from the group consisting of a ginseng or red ginseng water dialysis layer, an entire ginseng or red ginseng extract, a ginseng or red ginseng polysaccharide, and a ginseng or red ginseng saponin, for preventing or improving an influenza virus infection.
(FR) La présente invention concerne une composition pharmaceutique contenant du xylitol en tant que principe actif, pour la prévention ou le traitement d'une infection par le virus grippal. En particulier, la composition pharmaceutique comprend en outre une ou plusieurs substances choisies dans le groupe constitué d'une couche de dialyse contre de l'eau de ginseng ou de ginseng rouge, d'un extrait entier de ginseng ou de ginseng rouge, d'un polysaccharide de ginseng ou de ginseng rouge, et d'une saponine de ginseng ou de ginseng rouge. En outre, la présente invention propose une composition diététique contenant du xylitol ; et une ou plusieurs substances choisies dans le groupe constitué d'une couche de dialyse contre de l'eau de ginseng ou de ginseng rouge, d'un extrait entier de ginseng ou de ginseng rouge, d'un polysaccharide de ginseng ou de ginseng rouge, et d'une saponine de ginseng ou de ginseng rouge, pour la prévention ou l'amélioration d'une infection par le virus grippal.
(KO) 본 발명은 자일리톨을 유효성분으로 함유하는 인플루엔자 바이러스 감염증 예방 또는 치료용 약학조성물에 관한 것으로, 상세하게는 상기 약학조성물은 인삼 또는 홍삼 물 투석층, 인삼 또는 홍삼 전체 추출물, 인삼 또는 홍삼 다당체 및 인삼 또는 홍삼 사포닌으로 이루어진 군에서 선택된 어느 하나 또는 2 이상을 더 포함하는 것을 특징으로 한다. 또한, 본 발명은 자일리톨; 및 인삼 또는 홍삼 물 투석층, 인삼 또는 홍삼 전체 추출물, 인삼 또는 홍삼 다당체 및 인삼 또는 홍삼 사포닌으로 이루어진 군에서 선택된 어느 하나 또는 2 이상을 포함하는 인플루엔자 바이러스 감염증 예방 또는 개선용 건강식품 조성물을 제공한다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)